Citation: | FAN Jun-fang, HU Jing, GENG Xu, ZHUANG Lan-gen, SHI Zhao-ming. Correlation between liver-controlled attenuation parameters and serum 25-hydroxyvitamin D level in patients with type 2 diabetes[J]. Chinese Journal of General Practice, 2021, 19(5): 794-797. doi: 10.16766/j.cnki.issn.1674-4152.001919 |
[1] |
洪文忠, 李奕萍. 血清γ-GT、CHE、Apelin及内脂素水平在非酒精性脂肪肝病患者中的诊疗价值[J]. 中华全科医学, 2020, 18(3): 463-466. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202003034.htm
|
[2] |
LALLUKKA S, YKI-JÄRVINEN H. Non-alcoholic fatty liver disease and risk of type 2 diabetes[J]. Best Pract Res Clin Endocrinol Metab, 2016, 30(3): 385-395. doi: 10.1016/j.beem.2016.06.006
|
[3] |
SAPONARO C, GAGGINI M, GASTALDELLI A. Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms[J]. Current Diabetes Reports, 2015, 15(6): 1-13. doi: 10.1007%2Fs11892-015-0607-4.pdf
|
[4] |
DING Y H, WEI T M, QIAN L Y, et al. Association between serum 25-hydroxyvitamin D and carotid atherosclerotic plaque in Chinese type 2 diabetic patients[J]. Medicine, 2017, 96(13): 6445. doi: 10.1097/MD.0000000000006445
|
[5] |
董智慧. 老年2型糖尿病患者25羟维生素D与糖脂代谢、颈动脉内膜中层厚度的关系[J]. 中国老年学杂志, 2020, 40(9): 1820-1823. doi: 10.3969/j.issn.1005-9202.2020.09.010
|
[6] |
ALHEWISHEL MA, BAHGAT M, AL HUWAIYSHIL A, et al. 25(OH)D serum level in non-diabetic and type Ⅱ diabetic patients: a cross-sectional study[J]. Cureus, 2020, 12(6): e8910. http://www.researchgate.net/publication/342545548_25OHD_Serum_Level_in_Non-Diabetic_and_Type_II_Diabetic_Patients_A_Cross-Sectional_Study/download
|
[7] |
李静波, 刘姝, 温博, 等. FibroTouch与B超、CT对脂肪肝的诊断价值比较[J]. 临床肝胆病杂志, 2016, 32(3): 459-462. doi: 10.3969/j.issn.1001-5256.2016.03.011
|
[8] |
KIM J, LEE H, LIM J, et al. The angiogenesis inhibitor ALS-L1023 from lemon-balm leaves attenuates high-fat diet-induced nonalcoholic fatty liver disease through regulating the visceral adipose-tissue function[J]. Int J Mol Sci, 2017, 18(4): 846-881. doi: 10.3390/ijms18040846
|
[9] |
KO Y H, WONG T C, HSU Y Y, et al. The correlation between body fat, visceral fat, and nonalcoholic fatty liver disease[J]. Metab Syndr Relat Disord, 2017, 15(6): 304-311. doi: 10.1089/met.2017.0001
|
[10] |
KWOK R, CHOI K C, WONG G L, et al. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study[J]. Gut, 2016, 65(8): 1359-1368. doi: 10.1136/gutjnl-2015-309265
|
[11] |
杨丽弘, 廖鑫, 张晗, 等. 2型糖尿病合并非酒精性脂肪肝肝纤维化与血清25-羟维生素D水平的关系研究[J]. 中国糖尿病杂志, 2018, 26(2): 117-122. doi: 10.3969/j.issn.1006-6187.2018.02.007
|
[12] |
齐潇雁, 肖新华. 非酒精性脂肪肝与2型糖尿病研究进展[J]. 中国现代医药杂志, 2015, 17(12): 89-92. doi: 10.3969/j.issn.1672-9463.2015.12.032
|
[13] |
SILVAGNO F, PESCARMONA G. Spotlight on vitamin D receptor, lipid metabolism and mitochondria: Some preliminary emerging issues[J]. Mol Cell Endocrinol, 2017, 450: 24-31. doi: 10.1016/j.mce.2017.04.013
|
[14] |
BORGES C C, SALLES A F, BRINGHENTI I, et al. Vitamin D deficiency increases lipogenesis and reduces beta-oxidation in the liver of diet-induced obese mice[J]. J Nutr Sci Vitaminol (Tokyo), 2018, 64(2): 106-115. doi: 10.3177/jnsv.64.106
|
[15] |
马世瞻, 赵家军. 内分泌与脂代谢[J]. 华西医学, 2018, 33(5): 491-498. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYX201805001.htm
|